Barclays’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Buy |
95,056
+41,256
| +77% | +$594K | ﹤0.01% | 2462 |
|
|
2025
Q1 | $372K | Sell |
53,800
-25,973
| -33% | -$180K | ﹤0.01% | 3010 |
|
|
2024
Q4 | $423K | Buy |
79,773
+9,701
| +14% | +$51.4K | ﹤0.01% | 3156 |
|
|
2024
Q3 | $256K | Buy |
70,072
+53,472
| +322% | +$195K | ﹤0.01% | 3362 |
|
|
2024
Q2 | $46K | Buy |
+16,600
| New | +$46K | ﹤0.01% | 3706 |
|
|
2024
Q1 | – | Sell |
-3,750
| Closed | -$5K | – | 4309 |
|
|
2023
Q4 | $5K | Buy |
+3,750
| New | +$5K | ﹤0.01% | 4093 |
|
|
2023
Q1 | – | Sell |
-100,000
| Closed | -$168K | – | 4455 |
|
|
2022
Q4 | $168K | Sell |
100,000
-193,769
| -66% | -$326K | ﹤0.01% | 3192 |
|
|
2022
Q3 | $361K | Hold |
293,769
| – | – | ﹤0.01% | 2761 |
|
|
2022
Q2 | $491K | Buy |
293,769
+86,159
| +42% | +$144K | ﹤0.01% | 2585 |
|
|
2022
Q1 | $511K | Sell |
207,610
-568,691
| -73% | -$1.4M | ﹤0.01% | 2789 |
|
|
2021
Q4 | $2.9M | Sell |
776,301
-180,440
| -19% | -$675K | ﹤0.01% | 1576 |
|
|
2021
Q3 | $6M | Buy |
956,741
+147,437
| +18% | +$924K | ﹤0.01% | 1148 |
|
|
2021
Q2 | $7.98M | Buy |
809,304
+774,833
| +2,248% | +$7.64M | ﹤0.01% | 1011 |
|
|
2021
Q1 | $322K | Buy |
34,471
+17,240
| +100% | +$161K | ﹤0.01% | 2906 |
|
|
2020
Q4 | $83K | Sell |
17,231
-5,382
| -24% | -$25.9K | ﹤0.01% | 3029 |
|
|
2020
Q3 | $92K | Sell |
22,613
-3,717
| -14% | -$15.1K | ﹤0.01% | 3069 |
|
|
2020
Q2 | $121K | Buy |
26,330
+12,689
| +93% | +$58.3K | ﹤0.01% | 3035 |
|
|
2020
Q1 | $44K | Sell |
13,641
-27,370
| -67% | -$88.3K | ﹤0.01% | 3155 |
|
|
2019
Q4 | $177K | Buy |
41,011
+21,519
| +110% | +$92.9K | ﹤0.01% | 3233 |
|
|
2019
Q3 | $77K | Sell |
19,492
-5,157
| -21% | -$20.4K | ﹤0.01% | 3526 |
|
|
2019
Q2 | $115K | Buy |
24,649
+13,386
| +119% | +$62.5K | ﹤0.01% | 3516 |
|
|
2019
Q1 | $48K | Buy |
11,263
+10,842
| +2,575% | +$46.2K | ﹤0.01% | 3673 |
|
|
2018
Q4 | $1K | Sell |
421
-14,560
| -97% | -$34.6K | ﹤0.01% | 4036 |
|
|
2018
Q3 | $64K | Buy |
14,981
+257
| +2% | +$1.1K | ﹤0.01% | 3638 |
|
|
2018
Q2 | $54K | Sell |
14,724
-49,395
| -77% | -$181K | ﹤0.01% | 3271 |
|
|
2018
Q1 | $269K | Sell |
64,119
-38,795
| -38% | -$163K | ﹤0.01% | 2673 |
|
|
2017
Q4 | $605K | Buy |
102,914
+81,624
| +383% | +$480K | ﹤0.01% | 1934 |
|
|
2017
Q3 | $91K | Sell |
21,290
-55,998
| -72% | -$239K | ﹤0.01% | 2728 |
|
|
2017
Q2 | $295K | Buy |
77,288
+65,471
| +554% | +$250K | ﹤0.01% | 2218 |
|
|
2017
Q1 | $31K | Buy |
11,817
+11,293
| +2,155% | +$29.6K | ﹤0.01% | 3251 |
|
|
2016
Q4 | $2K | Buy |
524
+344
| +191% | +$1.31K | ﹤0.01% | 3635 |
|
|
2016
Q3 | $1K | Sell |
180
-3,435
| -95% | -$19.1K | ﹤0.01% | 3809 |
|
|
2016
Q2 | $15K | Buy |
+3,615
| New | +$15K | ﹤0.01% | 2899 |
|